These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2431109)

  • 21. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
    J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptor system involving adenylate cyclase in canine caudate nucleus.
    Maeno H; Sano K; Nishikori K; Noshiro O; Sato A; Yoneda T; Usuda S; Iwanami S
    Adv Biochem Psychopharmacol; 1983; 36():175-83. PubMed ID: 6344564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology of mesocortical dopamine neurons.
    Bannon MJ; Roth RH
    Pharmacol Rev; 1983 Mar; 35(1):53-68. PubMed ID: 6138783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
    Sibley DR; Creese I
    Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.
    Felder CC; Jose PA; Axelrod J
    J Pharmacol Exp Ther; 1989 Jan; 248(1):171-5. PubMed ID: 2563286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
    Amenta F; Ricci A; Tayebati SK; Zaccheo D
    Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SK&F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography.
    O'Sullivan GJ; Roth BL; Kinsella A; Waddington JL
    Eur J Pharmacol; 2004 Feb; 486(3):273-80. PubMed ID: 14985049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins.
    Liu LX; Burgess LH; Gonzalez AM; Sibley DR; Chiodo LA
    Synapse; 1999 Feb; 31(2):108-18. PubMed ID: 10024007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1989 Feb; 248(2):514-20. PubMed ID: 2465405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.
    Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB
    Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diversity of dopamine receptors: new molecular and pharmacological developments.
    Hartman DS; Lanau F
    Pol J Pharmacol; 1997 Aug; 49(4):191-9. PubMed ID: 9437762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dopaminergic modifications caused by neuroleptics. Functional and therapeutic hypotheses on tardive dyskinesias].
    Tassin JP
    Encephale; 1988 Sep; 14 Spec No():157-62. PubMed ID: 2905643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
    Van Leeuwen DH; Eisenstein J; O'Malley K; MacKenzie RG
    Mol Pharmacol; 1995 Aug; 48(2):344-51. PubMed ID: 7651368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dopamine effect on ionic conduction and adenyl cyclase activity in the central nervous system of the pond snail].
    Prudnikov IM; Osipenko ON; Kastrikina TF; Tsyvkin VN
    Neirofiziologiia; 1992; 24(4):437-51. PubMed ID: 1436209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine-sensitive adenylyl cyclase: a receptor mechanism for dopamine.
    Kebabian JW
    Adv Biochem Psychopharmacol; 1978; 19():131-54. PubMed ID: 29445
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopaminergic regulation of aldosterone secretion. Biochemical mechanisms and pharmacology.
    Missale C; Lombardi C; Sigala S; Spano PF
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):93S-95S. PubMed ID: 2166536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The history and pharmacology of dopamine agonists.
    Lataste X
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):118-23. PubMed ID: 6713309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.